Evidence map›Paper›PMID 36601982›Full record

Observational studyHaematologica2023

Efficacy, safety, and cost of mobilization strategies in multiple myeloma: a prospective, observational study.

Binod Dhakal, Mei-Jei Zhang, Linda J Burns, Xiaoying Tang, Christa Meyer, Lih-Wen Mau, Ajay K Nooka, Edward Stadtmauer, Ivana N Micallef, Joseph McGuirk and 13 more

Abstract readObservational StudyLetter
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Haematologica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Binod DhakalBMT and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee.
Mei-Jei ZhangDivision of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI; CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee.
Linda J BurnsCIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee.
Xiaoying TangCIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee.
Christa MeyerCIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN.
Lih-Wen MauCIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN.
Ajay K NookaDepartment of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA.
Edward StadtmauerUniversity of Pennsylvania Abramson Cancer Center, Philadelphia, PA.
Ivana N MicallefDivision of Hematology, Mayo Clinic, Rochester, MN.
Joseph McGuirkDivision of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Kansas City.
Luciano CostaDivision of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL.
Mark B JuckettDepartment of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN.
Nina ShahDivision of Hematology-Oncology; University of California San Francisco, San Francisco, CA.
Richard E ChamplinDepartment of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston.
Saad Z UsmaniDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York.
Sherif S FaragDivision of Hematology and Oncology, Indiana University School of Medicine, Indianapolis, IN.
Taiga NishihoriDepartment of Blood and Marrow Transplant and Cellular Immunotherapy (BMT CI), Moffitt Cancer Center, Tampa, FL.
Vivek RoyBlood and Marrow Transplant Program, Mayo Clinic, Jacksonville, FL.
Andrew BodifordUS Medical Affairs - Transplantation, Sanofi, Bridgewater, NJ.
Yvonne J BarnesUS Medical Affairs - Hematology Oncology, Sanofi Specialty Care, Cambridge, MA.
Edward J DreaUS Medical - Oncology Medical Value and Outcomes, Sanofi Specialty Care, Cambridge, MA.
Parameswaran HariCIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee.
Mehdi HamadaniBMT and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee. mhamadani@mcw.edu.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Data Resource for Analyzing Blood &Marrow TransplantsU24CA076518 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Amy M Moskop, Bronwen Shaw · 1998 to 2026
$105.2M
Unfolded Protein Response and Autophagy in T Helper Cell Effector FunctionP20GM121176 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI VOJO P DERETIC · 2017 to 2026
$24.9M
NCI NIH HHS P30 CA008748NCI NIH HHS U24 CA076518NIGMS NIH HHS P20 GM121176
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hematopoietic Stem Cell TransplantationHeterocyclic CompoundsMultiple MyelomaBenzylaminesGranulocyte Colony-Stimulating FactorHematopoietic Stem Cell MobilizationHumansProspective StudiesTransplantation, AutologousBenzylaminesGranulocyte Colony-Stimulating FactorHeterocyclic Compounds

Identifiers

PMID36601982
PMCPMC10388259

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.